Discovery of ONO-8590580: A novel, potent and selective GABAA 5 negative allosteric modulator for the treatment of cognitive disorders
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS(2020)
Abstract
The identification and SAR development of a series of negative allosteric modulators of the GABAA alpha 5 receptor is described. This novel series of compounds was optimised to provide analogues with high GABAA alpha 5 binding affinity, high alpha 5 negative allosteric modulatory activity, good functional subtype selectivity and low microsomal turnover, culminating in identification of ONO-8590580.
MoreTranslated text
Key words
GABAA alpha 5,Negative allosteric modulator,Cognition enhancement,ONO-8590580
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined